Jaclyn Jones, DO
Orthopaedic Surgery · Tulsa, OKNPI 1003001785
Payments from drug & device makers
Across 176 payments — averaging $59.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$8K
- Vericel Corporation$2K
- Pylant Medical$642
- Inari Medical, Inc.$191
- Amgen$79
- Pacira Therapeutics, Inc.$63
- plus $219 from 8 others
What the payments were for
- Speaking & faculty fees$1,40013%
- Travel & lodging$3,37332%
- Food & beverage$5,19650%
- Education$4564%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 144 | $7,696 |
| Vericel Corporation | 7 | $1,534 |
| Pylant Medical | 5 | $642 |
| Inari Medical, Inc. | 1 | $191 |
| Amgen(2 entities) | 5 | $79 |
| Pacira Therapeutics, Inc. | 4 | $63 |
| Vertex | 2 | $48 |
| Si-bone, Inc. | 1 | $35 |
| Providence Medical Technology, Inc. | 1 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Boston Scientific | 1 | $24 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Radius Health, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,425 in reported general payments places this provider in the 70th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 122 | $1,335 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 76 | $949 |
| Ondansetron OdtOndansetron | 113 | $841 |
| Celecoxib | 31 | $546 |
| Cyclobenzaprine Hcl | 88 | $469 |
| Methylprednisolone | 44 | $368 |
| Meloxicam | 29 | $56 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tulsa
- Yogesh MittalTulsa$6.7M
- Brian ChalkinTulsa$1.9M
- Sarat KunapuliTulsa$170K
- Kasra AhmadiniaTulsa$138K
- Keivan AbtahiTulsa$77K
- Rodney PlasterTulsa$61K
- Garrett WallerTulsa$52K
- Landon StallingsTulsa$46K
- Travis SmallTulsa$39K
- Blake ShockleyTulsa$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.